Extracellular vesicles for Alzheimer’s disease therapy: mechanisms, engineering strategies, and clinical translation

Abstract

Alzheimer’s disease (AD), a progressive neurodegenerative disorder, remains a major global health challenge owing to its complex pathogenesis and the presence of the blood-brain barrier (BBB), which substantially limits the delivery of effective therapeutics to the brain. Extracellular vesicles (EVs), which exhibit favorable biocompatibility, low immunogenicity, and the potential to cross or bypass the BBB under specific conditions, have emerged as promising therapeutic agents and delivery platforms for AD. This review focuses on the therapeutic potential of EV-based interventions in AD and summarizes recent advances in EV-mediated modulation of AD-related pathological processes, including amyloid-β (Aβ) clearance, tau protein regulation, neuroinflammation suppression, oxidative stress attenuation, and synaptic repair. Although EV-based therapies offer notable advantages, such as targeted BBB penetration and reduced immunogenic responses, their clinical translation remains constrained by safety concerns, including off-target effects, dose-dependent toxicity, and potential disturbances in neuroplasticity. In addition, this review discusses EV engineering strategies aimed at regulating the gut-brain axis (GBA), enhancing brain targeting, and advancing clinical translation. EV-based therapeutic interventions should therefore be developed within a safety-oriented framework supported by rigorous short- and long-term toxicological evaluation. Overall, this review highlights the therapeutic promise of EVs for AD while underscoring the need for rational engineering, standardized characterization, and safety-centered translational strategies to ensure clinical feasibility.

Keywords

Alzheimer’s disease / extracellular vesicles / MISEV2023 / engineering / clinical translation / gut-brain axis / intranasal delivery

References

[1] Frisoni GB,Hansson O,Nichols E.et al. New landscape of the diagnosis of Alzheimer’s disease Lancet 2025 406 1389 407

[2] Reiss AB,Housny M,Gulkarov S.et al. Role of apolipoprotein E in Alzheimer’s disease pathogenesis, prognosis and treatment Discov Med 2024 36 1917 32

[3] Testo AA,Roundy G,Dumas JA. Cognitive decline in Alzheimer’s disease. In: Kidd EJ, Newhouse PA, Editors. Neurobiology of Alzheimer’s disease. Cham: Springer Nature Switzerland; 2025. pp. 181-95

[4] 2024 Alzheimer’s disease facts and figures Alzheimers Dement 2024 20 3708 821 PMC11095490

[5] Soni U,Singh K,Jain D,Pujari R. Exploring Alzheimer’s disease treatment: Established therapies and novel strategies for future care Eur J Pharmacol 2025 998 177520

[6] Chew CS,Lee JY,Ng KY,Koh RY,Chye SM. Resilience mechanisms underlying Alzheimer’s disease Metab Brain Dis 2025 40 86

[7] Zhang J,Kong G,Yang J,Pang L,Li X. Pathological mechanisms and treatment progression of Alzheimer’s disease Eur J Med Res 2025 30 625 PMC12261696

[8] Beder N,Belkhelfa M,Leklou H. Involvement of inflammasomes in the pathogenesis of Alzheimer’s disease J Alzheimers Dis 2024 102 11 29

[9] Ziar R,Tesar PJ,Clayton BLL. Astrocyte and oligodendrocyte pathology in Alzheimer’s disease Neurotherapeutics 2025 22 e00540 PMC12047399

[10] Wang C,Wang S,Xue Y.et al. Intravenous administration of blood-brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system Nat Biotechnol 2025 43 1783 9

[11] Han J,Zhang X,Kang L,Guan J. Extracellular vesicles as therapeutic modulators of neuroinflammation in Alzheimer’s disease: a focus on signaling mechanisms J Neuroinflammation 2025 22 120 PMC12023694

[12] Yin T,Liu Y,Ji W.et al. Engineered mesenchymal stem cell-derived extracellular vesicles: a state-of-the-art multifunctional weapon against Alzheimer’s disease Theranostics 2023 13 1264 85 PMC10008732

[13] Jeppesen DK,Zhang Q,Coffey RJ. Extracellular vesicles and nanoparticles at a glance J Cell Sci 2024 137 jcs260201 PMC11658686

[14] Dhapola R,Kumari S,Sharma P.et al. Deciphering molecular and signaling pathways of extracellular vesicles-based therapeutics for Alzheimer’s disease Mol Neurobiol 2025 62 15430 49

[15] Welsh JA,Goberdhan DC,O’Driscoll L,Théry C,Witwer KW. MISEV2023: an updated guide to EV research and applications J Extracell Vesicles 2024 13 e12416 PMC10891433

[16] Welsh JA,Goberdhan DCI,O’Driscoll L.et al. ; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches J Extracell Vesicles 2024 13 e12404 PMC10850029

[17] Gao G,Li C,Ma Y.et al. Neural stem cell-derived extracellular vesicles mitigate Alzheimer’s disease-like phenotypes in a preclinical mouse model Signal Transduct Target Ther 2023 8 228 PMC10264449

[18] Zhang W,Uyemura R,Zhong K,Guo R,Zhong L. Current advances and future perspectives on mesenchymal stem cell-derived extracellular vesicles in Alzheimer’s disease Aging Dis 2024 15 2015 27 PMC11346404

[19] Rather HA,Almousa S,Craft S,Deep G. Therapeutic efficacy and promise of stem cell-derived extracellular vesicles in Alzheimer’s disease and other aging-related disorders Ageing Res Rev 2023 92 102088 PMC10842260

[20] Zhai Y,Gao F,Shi S.et al. Noninvasive optogenetics realized by iPSC-derived tentacled carrier in Alzheimer’s disease treatment Adv Mater 2025 37 e2419768

[21] Liu T,Rong Z,Li J,Wu H,Wei J. Three-dimensional interactive network: Mitochondrial-metabolic-calcium homeostasis driving Alzheimer’s disease Genes Dis 2026 13 101846 PMC12874427

[22] Takahashi T,Muguruma K. Alzheimer’s disease: from pathogenesis to emerging therapeutic targets J Clin Med 2026 15 2357 PMC13027111

[23] Ferrari-Souza JP,Povala G,Rahmouni N.et al. Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease Nat Neurosci 2026 29 81 7 PMC12779546

[24] Amelimojarad M,Amelimojarad M,Cui X. The emerging role of brain neuroinflammatory responses in Alzheimer’s disease Front Aging Neurosci 2024 16 1391517 PMC11253199

[25] Dash UC,Bhol NK,Swain SK.et al. Oxidative stress and inflammation in the pathogenesis of neurological disorders: mechanisms and implications Acta Pharm Sin B 2025 15 15 34 PMC11873663

[26] Kemna RE,Kueck PJ,Honea R.et al. Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer’s disease Alzheimers Dement 2025 21 e70390 PMC12213451

[27] Lattmann R,Vockert N,Bernal J.et al. Dysfunction of the episodic memory network in the Alzheimer’s disease cascade Nat Commun 2026 17 3578 PMC13090369

[28] Jamann N,Montijn JS,Petersen N.et al. Layer 5 myelination gates corticothalamic coincidence detection Nat Commun 2025 16 10922 PMC12699038

[29] Schumacher J,Ray NJ,Hamilton CA.et al. Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer’s disease Brain 2022 145 1773 84 PMC9166545

[30] Carnevale LN,Banerjee P,Zhang X.et al. Redox regulation of neuroinflammatory pathways contributes to damage in Alzheimer’s disease brain Cell Chem Biol 2026 Epub ahead of print PMC13248890

[31] Yu Y,Yu S,Battaglia G,Tian X. Amyloid-β in Alzheimer’s disease: structure, toxicity, distribution, treatment, and prospects Ibrain 2024 10 266 89 PMC11427815

[32] Yu Y,Xiao W,Ma Z,Yi X,Zhong T,Li Z. Circulatory extracellular vesicles transport complement C1q for promoting neuronal amyloid-β production in Alzheimer’s disease J Neuroinflammation 2025 22 209 PMC12395740

[33] Sasmita AO,Depp C. A question of origins: non-neuronal sources of Amyloid-β Neurosci Bull 2026 42 1126 50 PMC13158349

[34] Pacheco-Quinto J,Clausen D,Pérez-González R.et al. Intracellular metalloprotease activity controls intraneuronal Aβ aggregation and limits secretion of Aβ via exosomes FASEB J 2019 33 3758 71 PMC6404562

[35] Wang C,Yang Y,Zhang X.et al. Secreted endogenous macrosomes reduce Aβ burden and ameliorate Alzheimer’s disease Sci Adv 2023 9 eade0293 PMC10219594

[36] Pineda-Lopez L,Aguillon D,Villar-Vesga J.et al. Plasma extracellular vesicles from APOE3 Christchurch carriers display a protective phenotype in early stages of autosomal dominant Alzheimer’s disease Alzheimers Dement 2026 22 e71148 PMC12823782

[37] Chinnathambi S,Kumarappan M,Malik S,Velmurugan G,Chandrashekar M. Neuron-derived extracellular vesicle-based diagnostics for Tau and Alzheimer’s disease Brain Network Disorders 2025 1 150 66

[38] Peng D,Liu T,Lu H.et al. Intranasal delivery of engineered extracellular vesicles loaded with miR-206-3p antagomir ameliorates Alzheimer’s disease phenotypes Theranostics 2024 14 7623 44 PMC11626949

[39] Liu S,Fan M,Xu JX.et al. Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology J Neuroinflammation 2022 19 35 PMC8822863

[40] Ma X,Huang M,Zheng M.et al. ADSCs-derived extracellular vesicles alleviate neuronal damage, promote neurogenesis and rescue memory loss in mice with Alzheimer’s disease J Control Release 2020 327 688 702

[41] Li M,Chen S,Guo R.et al. Microglia-derived nanovesicles synchronize macroautophagy and chaperone-mediated autophagy for Alzheimer’s disease therapy Signal Transduct Target Ther 2025 10 360 PMC12583606

[42] Xie H,Wu F,Mao J.et al. The role of microglia in neurological diseases with involvement of extracellular vesicles Neurobiol Dis 2024 202 106700

[43] Cone AS,Yuan X,Sun L.et al. Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer’s disease-like phenotypes in a preclinical mouse model Theranostics 2021 11 8129 42 PMC8344012

[44] Apodaca LA, Baddour AAD, Garcia C Jr, et al. Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer’s disease Alzheimers Res Ther 2021 13 57 PMC7937214

[45] Huber CC,Callegari EA,Paez MD,Romanova S,Wang H. Heat shock-induced extracellular vesicles derived from neural stem cells confer marked neuroprotection against oxidative stress and Amyloid-β-Caused neurotoxicity Mol Neurobiol 2022 59 7404 12 PMC10088367

[46] Li B,Chen Y,Zhou Y.et al. Neural stem cell-derived exosomes promote mitochondrial biogenesis and restore abnormal protein distribution in a mouse model of Alzheimer’s disease Neural Regen Res 2024 19 1593 601 PMC10883488

[47] Li N,Shu J,Yang X,Wei W,Yan A. Exosomes derived from M2 microglia cells attenuates neuronal impairment and mitochondrial dysfunction in Alzheimer’s disease through the PINK1/Parkin pathway Front Cell Neurosci 2022 16 874102 PMC9096074

[48] Pourhadi M,Zali H,Ghasemi R,Faizi M,Mojab F,Soufi Zomorrod M. Restoring synaptic function: how intranasal delivery of 3D-cultured hUSSC exosomes improve learning and memory deficits in Alzheimer’s disease Mol Neurobiol 2024 61 3724 41

[49] Kwon H,Lee EH,Park SY.et al. Lactobacillus-derived extracellular vesicles counteract Aβ42-induced abnormal transcriptional changes through the upregulation of MeCP2 and Sirt1 and improve Aβ pathology in Tg-APP/PS1 mice Exp Mol Med 2023 55 2067 82 PMC10545704

[50] Calzoni E,Cusumano G,Bertoldi A.et al. Rhubarb-derived extracellular vesicles mitigate oxidative stress and metabolic dysfunction in an Alzheimer’s cellular model Nutrients 2025 17 3771 PMC12694416

[51] Chinnathambi S,Rangappa N,Chandrashekar M. Internalization of extracellular Tau oligomers in Alzheimer’s disease. Elsevier; 2025. pp. 1-29

[52] Singh M,Ali H,Renuka Jyothi S.et al. Tau proteins and senescent cells: targeting aging pathways in Alzheimer’s disease Brain Res 2024 1844 149165

[53] Asai H,Ikezu S,Tsunoda S.et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation Nat Neurosci 2015 18 1584 93 PMC4694577

[54] Jain N,Ulrich JD. TREM2 and microglia exosomes: a potential highway for pathological tau Mol Neurodegener 2022 17 73 PMC9670492

[55] Penney J,Ralvenius WT,Loon A.et al. iPSC-derived microglia carrying the TREM2 R47H/+ mutation are proinflammatory and promote synapse loss Glia 2024 72 452 69 PMC10904109

[56] Fowler SL,Behr TS,Turkes E.et al. Tau filaments are tethered within brain extracellular vesicles in Alzheimer’s disease Nat Neurosci 2025 28 40 8 PMC11706778

[57] Zhu B,Liu Y,Hwang S.et al. Trem2 deletion enhances tau dispersion and pathology through microglia exosomes Mol Neurodegener 2022 17 58 PMC9438095

[58] Qin Q,Teng Z,Liu C,Li Q,Yin Y,Tang Y. TREM2, microglia, and Alzheimer’s disease Mech Ageing Dev 2021 195 111438

[59] Lan G,Li A,Gonzalez-Ortiz F.et al. Higher plasma soluble TREM2 correlates with reduced cerebral tau accumulation in Alzheimer’s disease Mol Psychiatry 2025 30 3988 97

[60] Song Z,Xie X,Chen Y.et al. Innate immune sensing of Z-nucleic acids by ZBP1-RIPK1 axis drives neuroinflammation in Alzheimer’s disease Immunity 2025 58 2574 92.e9

[61] Wang J,Wu J,Ma X.et al. A double-edged sword: exploring the neuroprotective/damaging mechanisms of complement activation in Alzheimer’s disease Aging Health Res 2025 5 100267

[62] Harrell CR,Jovicic N,Djonov V,Arsenijevic N,Volarevic V. Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases Cells 2019 8 1605 PMC6952783

[63] Yu M,Ma H,Lai X,Wu J,Shen M,Yan J. Stem cell extracellular vesicles: a new dawn for anti-inflammatory treatment of neurodegenerative diseases Front Aging Neurosci 2025 17 1592578 PMC12289688

[64] Zhang J,He S,Xiao Q.et al. Engineered mesenchymal stem cell-derived extracellular vesicles overexpressing miR-146a alleviate neuroinflammation in Alzheimer’s disease Neural Regen Res 2026 21 4989 99

[65] Losurdo M,Pedrazzoli M,D’Agostino C.et al. Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer’s disease Stem Cells Transl Med 2020 9 1068 84 PMC7445021

[66] Xu X,Fan SS,Li J.et al. Integrated multi-omics analysis and cross-model validation reveal mitochondrial signatures in Alzheimer’s disease CNS Neurosci Ther 2025 31 e70634 PMC12559030

[67] Ashleigh T,Swerdlow RH,Beal MF. The role of mitochondrial dysfunction in Alzheimer’s disease pathogenesis Alzheimers Dement 2023 19 333 42

[68] D’Alessandro MCB,Kanaan S,Geller M,Praticò D,Daher JPL. Mitochondrial dysfunction in Alzheimer’s disease Ageing Res Rev 2025 107 102713

[69] Wang W,Qu Y,Li S.et al. Neuroprotective effects of curculigoside against Alzheimer’s disease via regulation oxidative stress mediated mitochondrial dysfunction in L-Glu-exposed HT22 cells and APP/PS1 mice Food Sci Hum Wellness 2023 12 1265 78

[70] Zhang Q,Li S,Chen H.et al. Reduction of oxidative stress and excitotoxicity by mesenchymal stem cell biomimetic Co-delivery system for cerebral ischemia-reperfusion injury treatment Small 2024 20 e2401045

[71] Huang T,Tong H,Zhou H.et al. ADSC-exosomes alleviate MTX-induced rat neuronal damage by activating Nrf2-ARE pathway J Mol Neurosci 2022 72 1334 44 PMC9170627

[72] Santos MFD,Roxo C,Solá S. Oxidative-signaling in neural stem cell-mediated plasticity: implications for neurodegenerative diseases Antioxidants 2021 10 1088 PMC8301193

[73] Gotoh S,Kawabori M,Yamaguchi S.et al. Intranasal administration of stem cell-derived exosome alleviates cognitive impairment against subarachnoid hemorrhage Exp Neurol 2025 386 115143

[74] Long Q,Upadhya D,Hattiangady B.et al. Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus Proc Natl Acad Sci U S A 2017 114 E3536 45 PMC5410779

[75] Du B,Zou Q,Wang X.et al. Multi-targeted engineered hybrid exosomes as Aβ nanoscavengers and inflammatory modulators for multi-pathway intervention in Alzheimer’s disease Biomaterials 2025 322 123403

[76] Depp C,Sun T,Sasmita AO.et al. Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease Nature 2023 618 349 57 PMC10247380

[77] Zhang J,Zhang Y,Wang J,Xia Y,Zhang J,Chen L. Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies Signal Transduct Target Ther 2024 9 211 PMC11344989

[78] Dhapola R,Beura SK,Sharma P,Singh SK,HariKrishnaReddy D. Oxidative stress in Alzheimer’s disease: current knowledge of signaling pathways and therapeutics Mol Biol Rep 2024 51 48

[79] Gaikwad S,Senapati S,Haque MA,Kayed R. Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer’s disease: evidence from clinical and preclinical studies Alzheimers Dement 2024 20 709 27 PMC10841264

[80] Gallego-Rudolf J,Wiesman AI,Pichet Binette A,Villeneuve S,Baillet S. PREVENT-AD Research Group Synergistic association of Aβ and tau pathology with cortical neurophysiology and cognitive decline in asymptomatic older adults Nat Neurosci 2024 27 2130 7 PMC11537964

[81] Sharma P,Kaur N,Vasal N,Solanki K,Sunkaria A. The mitochondria-synapse axis in Alzheimer’s disease: Lost coordination in early stages Ageing Res Rev 2026 119 103168

[82] Zhu X,Zhang L,Qin C. Hub genes and diagnostic model associated with mitochondrial function in Alzheimer’s disease Animal Model Exp Med 2026 9 237 48 PMC13042581

[83] Lee SH,Shin SM,Zhong P.et al. Reciprocal control of excitatory synapse numbers by Wnt and Wnt inhibitor PRR7 secreted on exosomes Nat Commun 2018 9 3434 PMC6109165

[84] Wu C,Chen Z,Li J.et al. Engineered nanovesicles amplify the crosstalk between neurogenesis and angiogenesis for pro-regenerative niche construction Nano Today 2026 66 102932

[85] Micci MA,Krishnan B,Bishop E.et al. Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes Mol Neurodegener 2019 14 25 PMC6570890

[86] Krämer-Albers EM,Werner HB. Mechanisms of axonal support by oligodendrocyte-derived extracellular vesicles Nat Rev Neurosci 2023 24 474 86

[87] Cai Y,Pinheiro-de-Sousa I,Slobodyanyuk M.et al. Myelin-axon interface vulnerability in Alzheimer’s disease revealed by subcellular proteomics and imaging of human and mouse brain Nat Neurosci 2025 28 1418 35 PMC12395420

[88] Xu J,Wang R,Luo W.et al. Oligodendrocyte progenitor cell-specific delivery of lipid nanoparticles loaded with Olig2 synthetically modified messenger RNA for ischemic stroke therapy Acta Biomater 2024 174 297 313

[89] Sasmita AO,Depp C,Nazarenko T.et al. Oligodendrocytes produce amyloid-β and contribute to plaque formation alongside neurons in Alzheimer’s disease model mice Nat Neurosci 2024 27 1668 74 PMC11374705

[90] Rajani RM,Ellingford R,Hellmuth M.et al. Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease PLoS Biol 2024 22 e3002727 PMC11265669

[91] Fan L,Liu C,Chen X.et al. Exosomes-loaded electroconductive hydrogel synergistically promotes tissue repair after spinal cord injury via immunoregulation and enhancement of myelinated axon growth Adv Sci 2022 9 e2105586 PMC9069372

[92] Zhang H,Xie XH,Xu SX.et al. Oligodendrocyte-derived exosomes-containing SIRT2 ameliorates depressive-like behaviors and restores hippocampal neurogenesis and synaptic plasticity via the AKT/GSK-3β pathway in depressed mice CNS Neurosci Ther 2024 30 e14661 PMC10912796

[93] Ji XY,Guo YX,Wang LB.et al. Microglia-derived exosomes modulate myelin regeneration via miR-615-5p/MYRF axis J Neuroinflammation 2024 21 29 PMC10801965

[94] Sun W,Chen Y,Yang Y.et al. Characteristics and transcriptomic analysis of cholinergic neurons derived from induced pluripotent stem cells with APP mutation in Alzheimer’s disease J Alzheimers Dis 2024 101 637 49

[95] Terry AV Jr, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer’s disease-related cognitive deficits: recent challenges and their implications for novel drug development J Pharmacol Exp Ther 2003 306 821 7

[96] Beier MT. Drug treatment for Alzheimer’s disease. Commentary: memantine treatment in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a randomized controlled trial Consult Pharm 2004 19 827 9

[97] Doody RS,Geldmacher DS,Farlow MR,Sun Y,Moline M,Mackell J. Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer’s disease: a subgroup analysis in patients already taking or not taking concomitant memantine Dement Geriatr Cogn Disord 2012 33 164 73

[98] Wang SS,Jia J,Wang Z. Mesenchymal stem cell-derived extracellular vesicles suppresses iNOS expression and ameliorates neural impairment in Alzheimer’s disease mice J Alzheimers Dis 2018 61 1005 13

[99] Bashirrohelleh MA,Bavarsad K,Khodadadi A,Shohan M,Asadirad A. Curcumin-enhanced stem cell exosomes: a novel approach to modulating neuroinflammation and improving cognitive function in a rat model of Alzheimer’s disease Eur J Pharmacol 2025 999 177695

[100] Jung YH,Jo HY,Kim DH.et al. Exosome-mediated mitochondrial regulation: a promising therapeutic tool for Alzheimer’s disease and Parkinson’s disease Int J Nanomedicine 2025 20 4903 17 PMC12011032

[101] Kang X,Jiang L,Chen X.et al. Exosomes derived from hypoxic bone marrow mesenchymal stem cells rescue OGD-induced injury in neural cells by suppressing NLRP3 inflammasome-mediated pyroptosis Exp Cell Res 2021 405 112635

[102] Kim JE,Ji YE,Hwang HJ.et al. Engineered MSC-EVs loaded with BDNF-enhancing neuropeptides via a non-disruptive method enhance post-stroke neuroregeneration via intranasal delivery J Nanobiotechnology 2025 23 594 PMC12395722

[103] Zhu C,Ren X,Liu C,Liu Y,Wang Y. Rbm8a regulates neurogenesis and reduces Alzheimer’s disease-associated pathology in the dentate gyrus of 5×FAD mice Neural Regen Res 2024 19 863 71 PMC10664127

[104] Wei R,Zhang L,Hu W,Shang X,He Y,Zhang W. Zeb2/Axin2-enriched BMSC-derived exosomes promote post-stroke functional recovery by enhancing neurogenesis and neural plasticity J Mol Neurosci 2022 72 69 81

[105] Gao G,Li C,Zhu J.et al. Induced neural stem/progenitor cell-derived extracellular vesicles promote recovery post-stroke Clin Transl Med 2022 12 e936 PMC9217134

[106] Zhu ZH,Jia F,Ahmed W.et al. Neural stem cell-derived exosome as a nano-sized carrier for BDNF delivery to a rat model of ischemic stroke Neural Regen Res 2023 18 404 9 PMC9396474

[107] Natale F,Leone L,Rinaudo M.et al. Neural stem cell-derived extracellular vesicles counteract insulin resistance-induced senescence of neurogenic niche Stem Cells 2022 40 318 31

[108] Alves SM,Lisboa-Filho PN,Zilli Vieira CL,Piacenti-Silva M. Alzheimer’s disease and gut-brain axis: drosophila melanogaster as a model Front Neurosci 2025 19 1543826 PMC11832644

[109] Hassan A,Huang Y,Mahjabina.et al. Emerging role of gut microbiota extracellular vesicle in neurodegenerative disorders and insights on their therapeutic management IMetaOmics 2024 1 e33 PMC12806478

[110] Chen X,Li Q,Zhang W.et al. Akkermansia muciniphila-derived extracellular vesicles alleviate colitis-related cognitive impairment via tryptophan metabolic reprogramming of the gut-brain axis Gut Microbes 2026 18 2611546 PMC12785224

[111] Ding L,Bian Q,Mou X,Chang X. Plant-derived exosome-like nanovesicles for CNS drug delivery and gut-brain axis modulation: a narrative review Int J Nanomedicine 2025 20 16093 123 PMC12765936

[112] Xie J,Cools L,Van Imschoot G.et al. Helicobacter pylori-derived outer membrane vesicles contribute to Alzheimer’s disease pathogenesis via C3-C3aR signalling J Extracell Vesicles 2023 12 e12306 PMC9931688

[113] Wang R,Zhang Y,Guo Y.et al. Plant-derived nanovesicles: promising therapeutics and drug delivery nanoplatforms for brain disorders Fundam Res 2025 5 830 50 PMC11997602

[114] Wang S,Zhang Y,Zeng Y.et al. Plant-derived vesicle-like nanoparticles for immunomodulation: mechanisms and applications Bioact Mater 2026 55 171 204 PMC12481952

[115] Cavaleri MP,Ardondi L,Vitali I.et al. Apple derived extracellular vesicles as positive modulators of glial inflammation and gut-brain axis signaling Phytomedicine 2026 156 158232

[116] Lieberman OJ,Douglas VC,LaHue SC. Reexamining cholinesterase inhibitors for the prevention and treatment of delirium in high-risk populations Crit Care 2023 27 129 PMC10064732

[117] Zhao S,Duan L,Lv Z.et al. Extracellular vesicle-mediated precision delivery of paclitaxel activates mitophagy to promote repair after spinal cord injury ACS Nano 2026 20 9387 406

[118] Cui GH,Guo HD,Li H.et al. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer’s disease Immun Ageing 2019 16 10 PMC6515654

[119] Zhang L,Lin J,Xiang K,Shi T,Guo B. Omnidirectional improvement of mitochondrial health in Alzheimer’s disease by multi-targeting engineered activated neutrophil exosomes J Control Release 2024 376 470 87

[120] Alvarez-Erviti L,Seow Y,Yin H,Betts C,Lakhal S,Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes Nat Biotechnol 2011 29 341 5

[121] Makhijani P,Valentino TR,Manwaring-Mueller M.et al. Amyloid-β-driven Alzheimer’s disease reshapes the colonic immune system in mice Cell Rep 2025 44 116109 PMC12520713

[122] Zhang S,Pan W,Ma C.et al. Dietary yam (Dioscorea opposita Thunb.) ameliorates Parkinson’s disease in mice via gut microbiota-driven mitochondrial improvement and neuroinflammation inhibition Nutrients 2026 18 1208 PMC13119290

[123] Connolly MG,Fliflet AM,Ravi P,Rosu DI,Boppart MD,Rhodes JS. Exercise-induced plasma-derived extracellular vesicles increase adult hippocampal neurogenesis Brain Research 2025 1869 150003

[124] Xu G,Jin J,Fu Z.et al. Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies Signal Transduct Target Ther 2025 10 255 PMC12350758

[125] Wu H,Gao P,Zhou W,Chen C,Wang M,Han L. Exosome-like nanovesicles (EVNs): a comprehensive overview of their isolation, characterization and biological applications Food Chem 2025 495 146575

[126] Yang M,Guo J,Fang L.et al. Quality and efficiency assessment of five extracellular vesicle isolation methods using the resistive pulse sensing strategy Anal Methods 2024 16 5536 44

[127] Chen H,Li Q. Recent advances in scalable exosome production: challenges and innovations Chin J Plast Reconstr Surg 2025 7 149 63

[128] Chen Y,Xu Y,Zheng Y.et al. Harnessing 3D cultured MSC exosomes through tangential flow filtration for enhanced diabetic wound healing Stem Cells Transl Med 2025 14 szaf064 PMC12668682

[129] Heikal LA,Hamdallah SI,El-Habashy SE,Ashour AA,El-Moslemany RM,El-Kamel AH. Microfluidics for separation, detection, and engineering of extracellular vesicles Adv Drug Deliv Rev 2026 231 115810

[130] Mukerjee N,Bhattacharya A,Maitra S.et al. Exosome isolation and characterization for advanced diagnostic and therapeutic applications Mater Today Bio 2025 31 101613 PMC11950786

[131] Yousif G,Qadri S,Parray A,Akhthar N,Shuaib A,Haik Y. Exosomes derived neuronal markers: immunoaffinity isolation and characterization Neuromolecular Med 2022 24 339 51

[132] Yang SJ,Lin AA,Shen H.et al. Microfluidic nanomagnetically isolated neuron- and astrocyte-derived extracellular vesicles to differentiate Lewy body and Alzheimer’s disease NPJ Biosens 2026 3 19 PMC12982126

[133] Dong D,Zhu T,Liao G.et al. Microfluidics-driven templating preparation of polymer vesicles with tailorable dimensions and rapid cellular internalization Biomater Sci 2025 13 2925 35

[134] Li H,Zhang J,Tan M.et al. Exosomes based strategies for cardiovascular diseases: opportunities and challenges Biomaterials 2024 308 122544

[135] Dilsiz N. A comprehensive review on recent advances in exosome isolation and characterization: toward clinical applications Transl Oncol 2024 50 102121 PMC11418158

[136] Wu S,Zhao Y,Zhang Z,Zuo C,Wu H,Liu Y. The advances and applications of characterization technique for exosomes: from dynamic light scattering to super-resolution imaging technology Photonics 2024 11 101

[137] Zhang K,Fang J. Extracellular vesicles in drug delivery: from quality assurance to therapeutic application Int J Nanomedicine 2026 21 579695 PMC13005977

[138] Li J,Wu H,Yu Z.et al. Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery Nat Commun 2024 15 5689 PMC11227508

[139] Ripoll L,Zickler AM,Vader P,El Andaloussi S,Verweij FJ,van Niel G. Biology and therapeutic potential of extracellular vesicle targeting and uptake Nat Rev Mol Cell Biol 2026 27 358 76

[140] Fang Y,Hao X,Fang B. Extracellular vesicle therapeutics in Alzheimer’s disease: mechanisms, progress, and prospects Extracell Vesicles Circ Nucl Acids 2026 7 394 424 PMC13074295

[141] De Palma ST,Hermans EC,Shamorkina TM.et al. Hypoxic preconditioning enhances the potential of mesenchymal stem cells to treat neonatal hypoxic-ischemic brain injury Stroke 2025 56 1872 82 PMC12180708

[142] Iyaswamy A,Thakur A,Guan XJ.et al. Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer’s disease Signal Transduct Target Ther 2023 8 404 PMC10590775

[143] Wang H,Sui H,Zheng Y.et al. Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK-3β pathway Nanoscale 2019 11 7481 96

[144] Qi Y,Guo L,Jiang Y,Shi Y,Sui H,Zhao L. Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles Drug Deliv 2020 27 745 55 PMC7269046

[145] Zhao X,Ge P,Lei S.et al. An exosome-based therapeutic strategy targeting neuroinflammation in Alzheimer’s disease with berberine and palmatine Drug Des Devel Ther 2023 17 2401 20 PMC10441573

[146] Jiang S,Cai G,Yang Z.et al. Biomimetic nanovesicles as a dual gene delivery system for the synergistic gene therapy of Alzheimer’s disease ACS Nano 2024 18 11753 68

[147] Han J,Sul JH,Lee J.et al. Engineered exosomes with a photoinducible protein delivery system enable CRISPR-Cas-based epigenome editing in Alzheimer’s disease Sci Transl Med 2024 16 eadi4830

[148] Huang M,Zheng M,Song Q.et al. Comparative proteomics inspired self-stimulated release hydrogel reinforces the therapeutic effects of MSC-EVs on Alzheimer’s disease Adv Mater 2024 36 e2311420

[149] Hong Y,Zhang H,Zeng L.et al. Universal microfluidic platform for multifunctional surface modification of small extracellular vesicles J Extracell Vesicles 2025 14 e70215 PMC12686133

[150] Shi X,Zhang L,Wu S.et al. A simple polydopamine-based platform for engineering extracellular vesicles with brain-targeting peptide and imaging probes to improve stroke outcome J Extracell Vesicles 2025 14 e70031 PMC11714163

[151] Guan X,Zhu M,Zhu H.et al. Oral natural extracellular vesicles for biomedical applications: advances and clinical perspectives J Adv Res 2026 83 1105 25 PMC13131399

[152] Rahgoshay M,Atashi A,Vaezi M,Ajorloo M,Amini-kafiabad S,Ahmadvand M. Engineered exosomes: advanced nanocarriers for targeted therapy and drug delivery in hematological malignancies Cancer Nano 2025 16 334

[153] Liz-Basteiro S,Sagastuy M,Perez JE.et al. Merging biological and synthetic nanoplatforms: magnetic engineering of extracellular vesicles via liposome fusion Nano Lett 2026 26 6190 200

[154] Huang Z,Fang Z,Ni K.et al. Peptide-engineered biomimetic nanoplatform with cell-membrane camouflage streamlines high-performance isolation and quantitation of extracellular vesicles ACS Sens 2025 10 5704 13

[155] Li M,Song X,Tu H.et al. A functionally tunable magnetic nanochains platform for N-glycoproteomic analysis of extracellular vesicles from ultratrace biofluids Nat Commun 2025 16 7646 PMC12357864

[156] Zhang F,Li J,Gao Y,Wei Y,Wen D,Wang Z. Stimulus switches for spatial-temporal precision in therapeutic delivery systems Nano Research 2025 18 94907571

[157] Mao M,Komes D,Zhao S.et al. Non-invasive neuromodulation assisted by exogenous stimuli-responsive nanoplatforms for Alzheimer’s disease and Parkinson’s disease therapy Innov Med 2025 3 100121

[158] Wu X,Jin S,Wang Q.et al. Calcium phosphate nanoparticle-immobilized macrophage-derived extracellular vesicle nanohybrid facilitates diabetic bone regeneration Adv Mater 2026 38 e09410

[159] Zhang X,Liu X,Zhou Q,Yao K. Extracellular vesicle-based delivery systems for nucleic acid therapeutics Mol Ther Nucleic Acids 2026 37 102870 PMC13049643

[160] Habiba UE,Sathyanarayanan R,Shamim S.et al. Intranasal administration of stem cells and their derivatives for neurological and respiratory disorders: a systematic review of human clinical trials Front Aging Neurosci 2026 18 1834543 PMC13190464

[161] Chen L,Xiao B. Rethinking delivery routes: oral administration of plant-derived exosome-like nanovesicles reduces the toxicity of intravenous injection Extracell Vesicles Circ Nucl Acids 2026 7 441 7 PMC13074265

[162] Ajeeb R,Clegg JR. Intrathecal delivery of macromolecules: clinical status and emerging technologies Adv Drug Deliv Rev 2023 199 114949

[163] Fowler MJ,Cotter JD,Knight BE,Sevick-Muraca EM,Sandberg DI,Sirianni RW. Intrathecal drug delivery in the era of nanomedicine Adv Drug Deliv Rev 2020 165-6 77 95 PMC8182643

[164] Lee G,Glicksman M,Patel R,Vanjani N,Kumthekar P. DDEL-10. Retrospective review of intra-CSF drug delivery: safety and drug distribution profiles of intracerebroventricular (ICV), lumbar intrathecal (LIT), and intra-cisterna magna (ICM) injections Neuro-Oncology 2023 25 v103 PMC10639759

[165] Fonseca LC,Lopes JA,Vieira J.et al. Intranasal drug delivery for treatment of Alzheimer’s disease Drug Deliv Transl Res 2021 11 411 25

[166] Arbabian A,Driscoll T,Li Y,Grant SC. Potential of intranasal delivery of human mesenchymal stem cells and extracellular vesicles for stroke therapy Acta Biomater 2026 214 23 39 PMC13050261

[167] Kim EH,Son JP,Oh GS.et al. Clinical scale MSC-derived extracellular vesicles enhance poststroke neuroplasticity in rodents and non-human primates J Extracell Vesicles 2025 14 e70110 PMC12183388

[168] Muhandiram S,Fazeli A. Does extracellular vesicle specificity truly exist? Cell Commun Signal 2026;24:125 PMC12918545

[169] Yu Y,Xu Z,Xu L,Lu D,Tang Y,Mai H. Plant extracellular vesicles as emerging neuroprotective agents for central nervous system disorders J Adv Res 2026 79 879 89 PMC12766175

[170] Iannotta D,A A,Kijas AW,Rowan AE,Wolfram J. Entry and exit of extracellular vesicles to and from the blood circulation Nat Nanotechnol 2024 19 13 20 PMC10872389

[171] Li H,Yu C,Markovic T,Nestler EJ,Dong Y. Chemical strategies for brain delivery of genomic therapy Nat Rev Chem 2025 9 841 54 PMC12831201

[172] Ye YL,Liu L. Engineering the future of nanomedicine: strategic approaches to extracellular vesicle-based drug administration regimens World J Stem Cells 2025 17 107080 PMC12305137

[173] Lam BWS,Tan M,Gao C.et al. Extracellular vesicles administered via intrathecal injection mediate safe delivery of nucleic acids to the central nervous system for gene therapy J Extracell Vesicles 2025 14 e70116 PMC12230351

[174] Xue Y,Wang C,Li H.et al. Lipid nanoparticles enhance mRNA delivery to the central nervous system upon intrathecal injection Adv Mater 2025 37 e2417097 PMC12245596

[175] Zheng Y,Qin Y,He Q.et al. Enhanced delivery of oral biomacromolecules through edible plant-derived nanovehicles: exploiting the self-amplifying trancytosis feedback loop and phosphatidic acid ACS Nano 2026 20 1710 31

[176] Zheng Y,Wang T,Zhang J.et al. Plant-derived nanovesicles: a promising frontier in tissue repair and antiaging J Agric Food Chem 2025 73 13159 77 PMC12147150

[177] Bydon M,Qu W,Moinuddin FM.et al. Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: phase I trial Nat Commun 2024 15 2201 PMC10984970

[178] Xie X,Song Q,Dai C.et al. Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial Gen Psychiatr 2023 36 e101143 PMC10582850

[179] Morita Y,Izawa H,Ohga H,Sugie H,Yamamoto T.et al. Safety and clinical efficacy on intranasal administration of mesenchymal stem cell-derived secretome in patients with Alzheimer’s disease and its future prospect Glycative Stress Res 2024 11 103 110

[180] Luo A,Yu H,Duan T.et al. Engineered mesenchymal stem cell-derived extracellular vesicles attenuate acute glaucoma-induced neuroinflammation by reprogramming microglial polarization Int Immunopharmacol 2026 179 116658

[181] Zhong R,Huang W,Chen C,Zhang B,Pu J,Zhang F. Advances in neural stem cells in aging and age-related neurodegenerative diseases. Ageing Neur Dis 2025;5:2

[182] Yu Y,Ma Z,Li T,Xiao W,Li Z. Neuronal extracellular vesicles carrying APOE downregulate filament actin polymerization signaling to inhibit synapse formation in Alzheimer’s disease J Extracell Vesicles 2026 15 e70248 PMC12974907

[183] Kou M,Huang L,Yang J.et al. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Dis 2022;13:580 PMC9252569

[184] Takakura Y,Hanayama R,Akiyoshi K.et al. Quality and safety considerations for therapeutic products based on extracellular vesicles Pharm Res 2024 41 1573 94 PMC11362369